Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012 (2012), Article ID 105205, 7 pages
http://dx.doi.org/10.1155/2012/105205
Review Article

Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet’s Disease

1Department of Immunology and Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki 216-8511, Japan
2Department of Medicine, Self-Defense Forces Central Hospital, Tokyo 154-8532, Japan

Received 16 July 2012; Accepted 23 August 2012

Academic Editor: Kamal D. Moudgil

Copyright © 2012 Jun Shimizu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behcet's disease,” The New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Melikoglu, S. Uysal, J. G. Krueger et al., “Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers,” Journal of Immunology, vol. 177, no. 9, pp. 6415–6421, 2006. View at Google Scholar · View at Scopus
  3. M. Ben Ahmed, H. Houman, M. Miled, K. Dellagi, and H. Louzir, “Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease,” Arthritis and Rheumatism, vol. 50, no. 7, pp. 2291–2295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Koarada, Y. Haruta, Y. Tada et al., “Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behçet's disease,” Rheumatology, vol. 43, no. 7, pp. 843–851, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Houman, A. Hamzaoui, I. Ben Ghorbal, M. Khanfir, M. Feki, and K. Hamzaoui, “Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations,” Journal of Autoimmunity, vol. 23, no. 3, pp. 267–273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Ilhan, T. Demir, P. Türkçüoǧlu, B. Turgut, N. Demir, and A. Gödekmerdan, “Th1 polarization of the immune response in uveitis in Behçet's disease,” Canadian Journal of Ophthalmology, vol. 43, no. 1, pp. 105–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Dalghous, J. Freysdottir, and F. Fortune, “Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD,” Scandinavian Journal of Rheumatology, vol. 35, no. 6, pp. 472–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Imamura, M. S. Kurokawa, H. Yoshikawa et al., “Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 371–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Nara, M. S. Kurokawa, S. Chiba et al., “Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease,” Clinical and Experimental Immunology, vol. 152, no. 2, pp. 245–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Nagafuchi, M. Takeno, H. Yoshikawa et al., “Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 363–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Choe, W. T. Chung, S. W. Lee et al., “Regional distinction for the clinical severity of Behçet's disease in Korea: four university-based medical centre studies,” Clinical and Experimental Rheumatology, vol. 28, no. 4, supplement 60, pp. S20–S26, 2010. View at Google Scholar · View at Scopus
  12. G. Mumcu, T. Ergun, N. Inanc et al., “Oral health is impaired in Behçet's disease and is associated with disease severity,” Rheumatology, vol. 43, no. 8, pp. 1028–1033, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Yokota, S. Hayashi, Y. Araki et al., “Characterization of Streptococcus sanguis isolated from patients with Behcet's disease,” Microbiology and Immunology, vol. 39, no. 9, pp. 729–732, 1995. View at Google Scholar · View at Scopus
  14. H. Yanagihori, N. Oyama, K. Nakamura, N. Mizuki, K. Oguma, and F. Kaneko, “Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1534–1540, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Mizushima, K. Hoshi, T. Matsuda et al., “Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease—a multicenter study,” Journal of Rheumatology, vol. 16, no. 4, pp. 506–511, 1989. View at Google Scholar · View at Scopus
  16. International Study Group for Behçet's Disease, “Criteria for diagnosis of Behçet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990. View at Google Scholar
  17. I. Fresko, H. Yazici, M. Bayramicli, S. Yurdakul, and C. Mat, “Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome,” Annals of the Rheumatic Diseases, vol. 52, no. 8, pp. 619–620, 1993. View at Google Scholar · View at Scopus
  18. A. K. Dudani and R. S. Gupta, “Immunological characterization of a human homolog of the 65-kilodalton mycobacterial antigen,” Infection and Immunity, vol. 57, no. 9, pp. 2786–2793, 1989. View at Google Scholar · View at Scopus
  19. T. Lehner, E. Lavery, R. Smith, R. van der Zee, Y. Mizushima, and T. Shinnick, “Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome,” Infection and Immunity, vol. 59, no. 4, pp. 1434–1441, 1991. View at Google Scholar · View at Scopus
  20. K. Pervin, A. Childerstone, T. Shinnick et al., “T cell epitope expression of mycobacterial and homologous human 65- kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease,” Journal of Immunology, vol. 151, no. 4, pp. 2273–2282, 1993. View at Google Scholar · View at Scopus
  21. H. Direskeneli, E. Ekşioǧlu-Demiralp, S. Yavuz et al., “T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease,” Journal of Rheumatology, vol. 27, no. 3, pp. 708–713, 2000. View at Google Scholar · View at Scopus
  22. S. Kaneko, N. Suzuki, N. Yamashita et al., “Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan,” Clinical and Experimental Immunology, vol. 108, no. 2, pp. 204–212, 1997. View at Google Scholar · View at Scopus
  23. T. Ergun, Ü. Ince, E. Ekşioǧlu-Demiralp et al., “HSP 60 expression in mucocutaneous lesions of Behçet's disease,” Journal of the American Academy of Dermatology, vol. 45, no. 6, pp. 904–909, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Deniz, U. Guc, N. Buyukbabani, and A. Gul, “HSP 60 expression in recurrent oral ulcerations of Behet's disease,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontology, vol. 110, no. 2, pp. 196–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. E. Bramanti, N. P. Dekker, F. Lozada-Nur, J. J. Sauk, and J. A. Regezi, “Heat shock (stress) proteins and γδ T lymphocytes in oral lichen planus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontology, vol. 80, no. 6, pp. 698–704, 1995. View at Google Scholar · View at Scopus
  26. B. Altincicek, J. Moll, N. Campos et al., “Cutting edge: human γδ T cells are activated by intermediates of 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis,” Journal of Immunology, vol. 166, no. 6, pp. 3655–3658, 2001. View at Google Scholar · View at Scopus
  27. M. T. Palmer and C. T. Weaver, “Autoimmunity: increasing suspects in the CD4 + T cell lineup,” Nature Immunology, vol. 11, no. 1, pp. 36–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Groh, A. Steinle, S. Bauer, and T. Spies, “Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells,” Science, vol. 279, no. 5357, pp. 1737–1740, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Hamazaoui, A. Hamazaoui, F. Hentati “ et al., “Phenotype and functional profile of T cells expressing γδ receptor from patients with active Behçet’s disease,” Journal of Rheumatology, vol. 21, no. 12, pp. 2301–2306, 1994. View at Google Scholar
  30. N. Yamashita, H. Kaneoka, S. Kaneko et al., “Role of γδ T lymphocytes in the development of Behcet's disease,” Clinical and Experimental Immunology, vol. 107, no. 2, pp. 241–247, 1997. View at Google Scholar · View at Scopus
  31. M. Mochizuki, N. Suzuki, M. Takeno et al., “Fine antigen specificity of human γδ T cell lines (Vγ9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis,” European Journal of Immunology, vol. 24, no. 7, pp. 1536–1543, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Lu, J. Wang, F. Zhang et al., “Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells,” Journal of Immunology, vol. 184, no. 8, pp. 4295–4306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Noubade, D. N. Krementsov, R. Del Rio et al., “Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis,” Blood, vol. 118, no. 12, pp. 3290–3300, 2011. View at Google Scholar
  34. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Wang, G. Han, J. Wang et al., “The role of STAT3 in antigen-IgG inducing regulatory CD4+Foxp3+T cells,” Cellular Immunology, vol. 246, no. 2, pp. 103–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Huber, J. Schrader, G. Fritz et al., “P38 MAP kinase signaling is required for the conversion of CD4+CD25 - T cells into iTreg,” PLoS ONE, vol. 3, no. 10, Article ID e3302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Pawaria and R. J. Binder, “CD91-dependent programming of T-helper cell responses following heat shock protein immunization,” Nature Communications, vol. 2, article 521, 2011. View at Publisher · View at Google Scholar
  39. G. H. M. van Puijvelde, T. van Es, E. J. A. van Wanrooij et al., “Induction of oral tolerance to HSP60 or an HSP60-peptide activates t cell regulation and reduces atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2677–2683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. T. Lin, C. T. Wang, M. E. Gershwin, and B. L. Chiang, “The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis,” Autoimmunity Reviews, vol. 10, no. 8, pp. 482–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Pay, I. Şimşek, H. Erdem, and A. Dinç, “Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells,” Rheumatology International, vol. 27, no. 5, pp. 417–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Hamzaoui, E. Bouali, I. Ghorbel, M. Khanfir, H. Houman, and A. Hamzaoui, “Expression of Th-17 and RORγt mRNA in Behçet's Disease,” Medical Science Monitor, vol. 17, no. 4, pp. CR227–CR234, 2011. View at Google Scholar · View at Scopus
  43. J. Shimizu, K. Takai, N. Fujiwara et al., “Excessive CD4+ T cells co-expressing interleukin-17 and interferon-ã in patients with Behçet's disease,” Clinical and Experimental Immunology, vol. 168, no. 1, pp. 68–74, 2012. View at Google Scholar
  44. G. Geri, B. Terrier, M. Rosenzwajg et al., “Critical role of IL-21 in modulating TH17 and regulatory Tcells in Behçet disease,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 655–664, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Nanke, S. Kotake, M. Goto, H. Ujihara, M. Matsubara, and N. Kamatani, “Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack,” Modern Rheumatology, vol. 18, no. 4, pp. 354–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Chi, X. Zhu, P. Yang et al., “Upregulated IL-23 and IL-17 in Behçet patients with active uveitis,” Investigative Ophthalmology and Visual Science, vol. 49, no. 7, pp. 3058–3064, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Shimizu, T. Izumi, N. Arimitsu et al., “Skewed TGFβ/Smad signaling pathway of T cells in patients with Behcet’s disease,” Clinical and Experimental Rheumatology. In press.
  48. N. Mizuki, A. Meguro, M. Ota et al., “Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci,” Nature Genetics, vol. 42, no. 8, pp. 703–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. E. F. Remmers, F. Cosan, Y. Kirino et al., “Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease,” Nature Genetics, vol. 42, no. 8, pp. 698–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Kol, A. H. Lichtman, R. W. Finberg, P. Libby, and E. A. Kurt-Jones, “Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells,” Journal of Immunology, vol. 164, no. 1, pp. 13–17, 2000. View at Google Scholar · View at Scopus
  51. J. Jin, D. J. Samuvel, X. Zhang et al., “Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells,” Molecular Immunology, vol. 49, no. 3, pp. 423–432, 2011. View at Google Scholar
  52. D. A. Vignali and V. K. Kuchroo, “IL-12 family cytokines: immunological playmakers,” Nature Immunology, vol. 13, no. 8, pp. 722–728, 2012. View at Google Scholar